Search results
FDA Approves a New Nasal Spray to Treat Migraines
Time via Yahoo News· 1 year agoCredit - Getty Images On Mar. 10, the U.S. Food and Drug Administration (FDA) approved a new treatment for migraines given as a nasal spray, according to...
AbbVie's Migraine Treatment Scores Canadian Approval
Benzinga via Yahoo Finance· 1 year agoHealth Canada has approved AbbVie Inc's (NYSE: ABBV) Ubrelvy (ubrogepant) for the acute treatment of migraine, with or without aura, in adults. Ubrelvy...
FDA Approves Pfizer's Fast Acting Migraine Drug Acquired Via $11B Biohaven Acquisition
Benzinga via Yahoo Finance· 1 year agoThe FDA has approved Pfizer Inc (NYSE: PFE) acquired Biohaven's Zavzpret (zavegepant), the first and...
These Drugs Are the New First Line of Defense Against Migraine
Verywell Health via Yahoo News· 1 month agoIllustration by Julie Bang for Verywell Health Fact checked by Nick Blackmer Key Takeaways CGRP...
Atypical Migraine: What to Know
Verywell Health via Yahoo News· 8 months agoA Stigmatized, Under-Researched Subtype of MigraineMedically reviewed by Nicholas R. Metrus, MD "Atypical migraine" is a term used to describe a migraine...
Pharma Stock Roundup: JNJ Beats on Q1 Earnings, MRK to Buy RXDX & Other Updates
Zacks via Yahoo Finance· 1 year agoThis week, J&J JNJ began the first-quarter earnings season for the drug and biotech sector with...
FDA Expands AbbVie's (ABBV) Qulipta Label in Chronic Migraine
Zacks via Yahoo Finance· 1 year agoFollowing FDA's label-expansion approval, AbbVie's (ABBV) Qulipta is the first and the only oral...
Biohaven's (BHVN) Zavegepant NDA for Migraine Accepted by FDA
Zacks via Yahoo Finance· 2 years agoThe FDA accepts Biohaven's (BHVN) NDA seeking approval for its pipeline candidate, zavegepant, as an...
Pfizer (PFE) Gets FDA Nod for Migraine Nasal Spray Zavzpret
Zacks via Yahoo Finance· 1 year agoZavzpret (zavegepant) is now part of Pfizer's (PFE) migraine drugs portfolio with the 2022...
AbbVie (ABBV) Gets EU Approval for Migraine Prevention Drug
Zacks via Yahoo Finance· 9 months agoFollowing the approval, AbbVie's (ABBV) Aquipta is the first and the only oral CGRP receptor...
